Monique da Silva
Corporate Officer/Principal chez ANAPTYSBIO, INC.
Postes actifs de Monique da Silva
Sociétés | Poste | Début | Fin |
---|---|---|---|
ANAPTYSBIO, INC. | Corporate Officer/Principal | - | - |
Historique de carrière de Monique da Silva
Anciens postes connus de Monique da Silva
Sociétés | Poste | Début | Fin |
---|---|---|---|
SPARK THERAPEUTICS, INC. | Public Communications Contact | 01/08/2016 | 01/01/2020 |
TECTONIC THERAPEUTIC, INC. | Public Communications Contact | 01/01/2020 | - |
Ogilvy Public Relations Worldwide, Inc.
Ogilvy Public Relations Worldwide, Inc. Miscellaneous Commercial ServicesCommercial Services Ogilvy Public Relations Worldwide, Inc. used to provide public relations and marketing solutions. It offers communications services within various global practices that includes consumer marketing, corporate, healthcare, social marketing, public affairs, technology and entertainment. The company was headquartered in New York, NY. | Corporate Officer/Principal | 10/03/2010 | - |
Formation de Monique da Silva
Bowdoin College | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Opérationnelle
Corporate Officer/Principal | 2 |
Public Communications Contact | 2 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 4 |
Commercial Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ANAPTYSBIO, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Ogilvy Public Relations Worldwide, Inc.
Ogilvy Public Relations Worldwide, Inc. Miscellaneous Commercial ServicesCommercial Services Ogilvy Public Relations Worldwide, Inc. used to provide public relations and marketing solutions. It offers communications services within various global practices that includes consumer marketing, corporate, healthcare, social marketing, public affairs, technology and entertainment. The company was headquartered in New York, NY. | Commercial Services |
Avrobio, Inc.
Avrobio, Inc. BiotechnologyHealth Technology AVROBIO, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Watertown, MA. | Health Technology |
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
- Bourse
- Insiders
- Monique da Silva
- Expérience